caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1023084522

Peter Veldkamp

Infectious DiseasePittsburgh, PAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
FACILITY AFFILIATIONS

Hospital & Facility Affiliations (1)

CCN 390164
Hospital
REFERRAL NETWORK

Where Peter Veldkamp's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 2 inbound referrers · 4 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Janet Durick
Diagnostic Radiology · Pittsburgh, PA
1655
Elliott Gozansky
Diagnostic Radiology · Birmingham, AL
1248
Refers patients to
Outbound — where patients go next
PhysicianPatientsVisits
UPMC PRESBYTERIAN SHADYSIDE69366
Janet Durick
Diagnostic Radiology · Pittsburgh, PA
1555
NPI 17109508451150
Iclal Ocak
Diagnostic Radiology · Chicago, IL
1127
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
65
Unique beneficiaries
—
Total services
93
Distinct HCPCS
4
Medicare payment
$5K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 346 Infectious Disease providers in PA — bottom quintile (cohort median 364).
PRESCRIBING · PART D · 2024
Total Rx claims
4,819
Beneficiaries
—
Total drug cost
$4.4M
Distinct drugs
108
Brand share
45.2%
Top prescribed drugs
Bictegrav/Emtricit/Tenofov Ala357 claims
Dolutegravir Sodium/Lamivudine332 claims
Atorvastatin Calcium274 claims
Amlodipine Besylate251 claims
Rosuvastatin Calcium229 claims
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.
QUALITY · MIPS · 2024
Final MIPS score
80.9
Quality
61.9
Cost
74.6
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.25%
Group